Paeds Vivas · nephrology-urology-fluids-and-electrolytes
IgA nephropathy and IgA vasculitis nephritis: Viva
Branching clinical structured oral on paediatric IgA nephropathy and IgA vasculitis nephritis: recognising synpharyngitic haematuria with a normal C3, applying the Oxford MEST-C score and prediction tool, building the treatment ladder from ACE inhibition to corticosteroids and budesonide, and managing crescentic and systemic disease.
On this page
Study tools
Target exams
Branch 1: Diagnosis and the defining features
The candidate should recognise that this boy has IgA nephropathy and state the defining feature: dominant mesangial IgA deposition on immunofluorescence. The clinical clue is the synpharyngitic timing of the macroscopic haematuria, appearing within one to two days of the sore throat, which is the single most discriminating bedside feature. A strong candidate should emphasise that the normal C3 and C4 exclude post-infectious glomerulonephritis, which has a one to two week latency and a low C3, and exclude lupus and membranoproliferative disease for the same reason. [1]
If the examiner presses on pathogenesis, the candidate should explain the multi-hit hypothesis: production of galactose-deficient IgA1, formation of antiglycan autoantibodies against it, generation of circulating immune complexes, and mesangial deposition with complement activation. The candidate should note that this is the same mechanism shared by IgA vasculitis nephritis, which is why the renal lesions are histologically identical. [1]
References3ShowHide
- [1]Floege J, Barratt J, Cook HT, et al Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV). Kidney Int, 2025.PMID 40975525
- [2]Trimarchi H, Barratt J, Cattran DC, et al Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int, 2017.PMID 28341274
- [3]Lv J, Xu D, Perkovic V, et al Corticosteroid therapy in IgA nephropathy. J Am Soc Nephrol, 2012.PMID 22539830